Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.
Erasca, Inc. faces a securities class action lawsuit after its stock plummeted 48% due to allegations of patent infringement by Revolution Medicines and the death of a patient treated with Erasca’s investigational drug ERAS-0015. The suit claims Erasca misled investors about the drug’s intellectual property protection…
Nintendo and The Pokémon Company’s patent lawsuit against Pocketpair, developer of Palworld, centers on game mechanics resembling Pokémon’s catch system. Despite initial claims for injunction and damages, recent legal developments suggest Nintendo’s potential recovery is capped at approximately $30,000, with no impact…
LG Energy Solution has finalized a patent licensing agreement with Sunwoda Electronic, ending nearly two years of litigation over battery technology patents. The deal, brokered by Tulip Innovation, includes mutual withdrawal of all ongoing legal actions and reinforces the importance of fair compensation for technologi…
The U.S. Supreme Court has ruled in favor of Hikma Pharmaceuticals in a patent infringement case brought by Amarin. This ruling resolves a significant dispute over patent rights and market competition between the two pharmaceutical companies.
JOOLA has resolved its patent infringement dispute with Paddletek Group and ProXR Pickleball, agreeing on royalty payments and inventory sell-through for specific paddle products. The settlement addresses JOOLA’s propulsion core patent and allows Paddletek and ProXR to phase out affected items by fall, while litigatio…
The U.S. Patent Trial and Appeal Board (PTAB) has reaffirmed its 2022 decision that the Broad Institute, MIT, and Harvard hold priority for the invention of CRISPR-Cas9 gene editing applications in eukaryotic cells. This ruling follows a remand from the U.S. Court of Appeals for the Federal Circuit, which requested re…
The Delhi High Court refused Novo Nordisk’s plea for an interim injunction against Dr. Reddy’s Laboratories over alleged infringement of Indian Patent No. 262697 related to Semaglutide. The Court found the patent prima facie vulnerable to revocation challenges based on prior claiming and lack of inventive step, allowi…
A U.S. District Court has awarded enhanced damages to the prevailing party in a patent infringement dispute initially addressed at the International Trade Commission (ITC). This decision highlights evolving judicial approaches to remedying IP violations and signals a robust enforcement environment for patent holders.…
Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.